Stay updated on Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2, reflecting a minor site update. The page content remains unchanged.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision label updated to v3.4.1 (replacing v3.4.0) on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedGlossary display is now shown; a new 'Last Update Submitted that Met QC Criteria' label and a 'No FEAR Act Data' notice, along with revision information 'v3.4.0', have been added. The previous label 'Last Update Submitted that met QC Criteria' (different casing), 'No FEAR Act data', and the older revision 'v3.3.4' have been removed.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page shows a new revision tag (v3.3.4) replacing the previous v3.3.3; there are no apparent changes to the study details, outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedLocations section updated to include Hubei; Hubei Locations removed; Revision: v3.3.3.SummaryDifference0.2%

- Check87 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial page.